BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 26382807)

  • 1. Personalized therapeutics of α₁-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Zhu LL; Feng ZJ; Zhou Q
    Clin Interv Aging; 2015; 10():621-2. PubMed ID: 25848238
    [No Abstract]   [Full Text] [Related]  

  • 2. Twelve-month medication persistence in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Koh JS; Cho KJ; Kim HS; Kim JC
    Int J Clin Pract; 2014 Feb; 68(2):197-202. PubMed ID: 24372906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study.
    Gravas S
    Eur Urol; 2015 Aug; 68(2):338-9. PubMed ID: 26149729
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to therapy for lower urinary tract symptoms: don't mistake association with causation!
    Penson DF
    Eur Urol; 2015 Sep; 68(3):426-7. PubMed ID: 25703576
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of benign prostatic hyperplasia.
    Nunes RV; Manzano J; Truzzi JC; Nardi A; Silvinato A; Bernardo WM;
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):95-99. PubMed ID: 28355368
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Twelve-Month Medication Persistence in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
    Kaplan SA
    J Urol; 2015 Oct; 194(4):1056. PubMed ID: 26382807
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
    Sarma AV; Wei JT
    N Engl J Med; 2012 Jul; 367(3):248-57. PubMed ID: 22808960
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment for benign prostatic hyperplasia: Where do we stand?
    Rossanese M; Crestani A; Inferrera A; Giannarini G; Bartoletti R; Tubaro A; Ficarra V
    Urologia; 2019 Aug; 86(3):115-121. PubMed ID: 31282310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Blockers, 5-α-Reductase Inhibitors, Acetylcholine, β3 Agonists, and Phosphodiesterase-5s in Medical Management of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: How Much Do the Different Formulations Actually Matter in the Classes?
    Chughtai B; Thomas D; Kaplan S
    Urol Clin North Am; 2016 Aug; 43(3):351-6. PubMed ID: 27476127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
    Schauer I; Madersbacher S
    Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.
    Marberger M
    Adv Ther; 2013 Apr; 30(4):309-19. PubMed ID: 23584673
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.